News

Atzumi, a dihydroergotamine (DHE) nasal powder, was approved by the Food and Drug Administration (FDA) for the acute ...
The U.S. Food and Drug Administration has approved Amneal Pharmaceuticals' self-administered migraine drug, giving way to a ...
Federal regulators have accepted Novo Nordisk’s application to produce a pill version of its injectable weight-loss ...
A first-in-human study of an investigational once-daily oral treatment for obesity (SYNT-101) demonstrates positive ...
A first-in-human study of an investigational once-daily oral treatment for obesity (SYNT-101) demonstrated positive preliminary data for the safe and effective redirection of nutrient absorption into ...